Summary sheet
The project consists of a quasi-equity loan to Greenbone, an Italian medtech company developing innovative bone-regenerating implants and bone replacement solutions to treat severe fractures and conditions, such as trauma and tumours causing extensive bone loss.
The aim is to finance the company's research, development and innovation (RDI) and costs scale up.
The promoter is a European R&D company specialised in development of an advance material for bone substitution. In addition to its own RDI capabilities, the promoter has developed a well-established network of collaborations with universities, research institutions and reputed industry partners. Companies producing innovative high quality products are key drivers of economic growth, productivity and social protection, and generally a source of high value added employment. The EIB support to this operation is expected to provide tangible value-added benefit, positively contributing to the promoter's R&D investments by lowering the associated cost of financing and offering loan maturity beyond the tenor usually offered by commercial banks as well as disbursement mechanics more suitable for the project's financing and more flexible than those normally proposed by the market.
The promoter's investment concerns RDI activities expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an Environmental Impact Assessment (EIA) under Directive 2011/92/EU. Full environmental details will be verified during appraisal.
The promoter is a private company, not operating in the utilities sector and not having the status of a contracting authority. Therefore, the EU directives on procurement are not applicable. Nevertheless, the promoter's procurement procedures are expected to be in line with the EIB's guidelines for private sector projects. Further details will be verified during the project due diligence.
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).
Documents
General enquiries and comments
The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.
Media enquiries
Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.
Complaints mechanism
Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.
Zero tolerance against fraud and corruption
The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.
Related publications